or Try an Advanced Search...

    Technical Analysis for CRDL - Cardiol Therapeutics Inc

    Grade Last Price % Change Price Change
    C 3.000 2.39% 0.070
    CRDL closed down 9.01 percent on Friday, May 17, 2024, on 1.78 times normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical CRDL trend table...
    Date Alert Name Type % Chg
    Bearish Engulfing Bearish 2.39%
    Slingshot Bullish Bullish Swing Setup 2.39%
    New 52 Week High Strength 2.39%
    Upper Bollinger Band Walk Strength 2.39%
    Earnings Movers Other 2.39%
    Outside Day Range Expansion 2.39%
    Wide Bands Range Expansion 2.39%
    Overbought Stochastic Strength 2.39%
    Upper Bollinger Band Touch Strength 2.39%
    New 52 Week Closing High Bullish -6.83%
    Older End-of-Day Signals for CRDL ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 4 hours ago
    Up 1 ATR about 7 hours ago
    Up 5% about 7 hours ago
    Rose Above 10 DMA about 7 hours ago
    10 DMA Support about 7 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    CRDL Chart by TradingView
    Basic chart:

    Profile

    Cardiol Therapeutics Inc Description

    Cardiol Therapeutics Inc is a Canada-based company engaged in the pharmaceutical business sector. The Company is focused on the research and commercial development of pharmaceutical cannabidiol products and targeted therapies for heart failure and cancer. It has research programs focused on development of nanotherapeutics to treat heart failure underway. The Company invests in development of formulations for three medical markets: commercializing a line of purity pharmaceutically-manufactured cannabidiol products in the market for medical cannabinoids; development of nanotechnologies designed to deliver cannabinoids and other anti-inflammatory drugs for the treatment of heart failure, a cause of death and hospitalization, and pursuing an immunotherapeutics program commencing with a cancer immunotherapeutic in combination with cannabinoids for treating Glioblastoma Multiforme.

    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Pharma Pharmaceutical Drug Cancer Drugs Heart Organ Systems Cannabinoid Blastoma Cannabidiol Cannabinoids Analgesics Glioblastoma Pharmaceutical Business Sector

    Is CRDL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 14 Cardiol Therapeutics Announces Phase II ARCHER Trial Presented at the World Congress on Acute Heart Failure 2024
    Apr 2 Cardiol Therapeutics Announces Year-End 2023 Update on Operations
    Feb 21 Cardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis
    Feb 15 Cardiol Therapeutics Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of Pericarditis
    Jan 24 Cardiol Therapeutics Regains Compliance with all Applicable Listing Standards of The Nasdaq Capital Market
    Jan 9 Cardiol Therapeutics Announces it has Exceeded 50% Enrollment in its Phase II ARCHER Trial in Acute Myocarditis
    See more CRDL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.27
    52 Week Low 0.87
    Average Volume 107,299
    200-Day Moving Average 1.656
    50-Day Moving Average 2.490
    20-Day Moving Average 2.762
    10-Day Moving Average 2.948
    Average True Range 0.190
    RSI (14) 56.52
    ADX 34.6
    +DI 27.570
    -DI 16.454
    Chandelier Exit (Long, 3 ATRs) 2.702
    Chandelier Exit (Short, 3 ATRs) 2.719
    Upper Bollinger Bands 3.251
    Lower Bollinger Band 2.273
    Percent B (%b) 0.67
    BandWidth 35.387
    MACD Line 0.168
    MACD Signal Line 0.147
    MACD Histogram 0.0214
    Fundamentals Value
    Market Cap 96.14 Million
    Num Shares 32.8 Million
    EPS -1.02
    Price-to-Earnings (P/E) Ratio -2.87
    Price-to-Sales 0.00
    Price-to-Book 3.94
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.455
    Resistance 3 (R3) 3.510 3.390 3.368
    Resistance 2 (R2) 3.390 3.256 3.363 3.338
    Resistance 1 (R1) 3.160 3.174 3.100 3.105 3.309
    Pivot Point 3.040 3.040 3.010 3.013 3.040
    Support 1 (S1) 2.810 2.906 2.750 2.755 2.551
    Support 2 (S2) 2.690 2.824 2.663 2.522
    Support 3 (S3) 2.460 2.690 2.493
    Support 4 (S4) 2.405